Insider Trades27 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 13, 2026 | Sell | PHVS | Berndt Modig | Chief Executive Officer | 2,292 | $34.97 | $2.4B | -4.54% | +82.74% | $80.2K | -1.70% | 10b5-1 | — |
| Jul 11, 2026 | Sell | PHVS | Peng Lu | Chief Medical Officer | 226 | $35.07 | $2.4B | -4.54% | +82.74% | $7.9K | -0.17% | — | — |
| Jun 29, 2026 | Sell | PHVS | Anne Lesage | Chief Early Development | 114,644 | $25.81 | $2.4B | -4.54% | +82.74% | $3.0M | -4.00% | 10b5-1 | — |
| Jun 25, 2026 | Sell | PHVS | Anne Lesage | Chief Early Development | 6,900 | $24.99 | $2.4B | -4.54% | +82.74% | $172.4K | -0.59% | 10b5-1 | — |
| Jun 25, 2026 | Sell | PHVS | Peng Lu | Chief Medical Officer | 59,400 | $18.45 | $2.4B | -4.54% | +82.74% | $1.1M | +0.00% | 10b5-1 | — |
| Jun 18, 2026 | Sell | PHVS | Peng Lu | Chief Medical Officer | 600 | $18.30 | $2.4B | -4.54% | +82.74% | $11.0K | +0.00% | 10b5-1 | — |
| Jun 15, 2026 | Sell | PHVS | Berndt Modig | Chief Executive Officer | 2,291 | $31.07 | $2.4B | -4.54% | +82.74% | $71.2K | -0.84% | 10b5-1 | — |
| Jun 12, 2026 | Sell | PHVS | Peng Lu | Chief Medical Officer | 117 | $32.20 | $2.4B | -4.54% | +82.74% | $3.8K | -0.18% | — | — |
| Jun 11, 2026 | Sell | PHVS | Peng Lu | Chief Medical Officer | 109 | $31.51 | $2.4B | -4.54% | +82.74% | $3.4K | -0.17% | — | — |
| Jun 4, 2026 | Sell | PHVS | Anna Nijdam | Principal Accounting Officer | 2,670 | $30.87 | $2.4B | -4.54% | +82.74% | $82.4K | -5.46% | — | — |
| May 21, 2026 | Sell | PHVS | David W. Nassif | CFO / CLO | 10,000 | $30.31 | $2.4B | -4.54% | +82.74% | $303.1K | -7.67% | — | — |
| May 21, 2026 | Sell | PHVS | Anna Nijdam | Principal Accounting Officer | 14,660 | $25.35 | $2.4B | -4.54% | +82.74% | $371.7K | +0.00% | — | — |
| May 18, 2026 | Sell | PHVS | Berndt Modig | Chief Executive Officer | 2,292 | $29.22 | $2.4B | -4.54% | +82.74% | $67.0K | -1.64% | — | — |
| May 15, 2026 | Sell | PHVS | Stefan Andreas Abele | Chief Technical Ops Officer | 8,748 | $29.82 | $2.4B | -4.54% | +82.74% | $260.9K | -19.91% | — | — |
| May 15, 2026 | Sell | PHVS | Wim Souverijns | Chief Commercial Officer | 10,000 | $29.92 | $2.4B | -4.54% | +82.74% | $299.2K | -18.15% | 10b5-1 | — |
| May 11, 2026 | Sell | PHVS | Peng Lu | Chief Medical Officer | 226 | $30.02 | $2.4B | -4.54% | +82.74% | $6.8K | -0.17% | — | — |
| May 1, 2026 | Sell | PHVS | Peng Lu | Chief Medical Officer | 28,332 | $16.38 | $2.4B | -4.54% | +82.74% | $464.1K | +0.00% | 10b5-1 | — |
| Apr 29, 2026 | Sell | PHVS | Peng Lu | Chief Medical Officer | 37,466 | $16.40 | $2.4B | -4.54% | +82.74% | $614.4K | +0.00% | 10b5-1 | — |
| Apr 29, 2026 | Sell | PHVS | Anne Lesage | Chief Early Development | 73,700 | $22.04 | $2.4B | -4.54% | +82.74% | $1.6M | -2.94% | 10b5-1 | — |
| Apr 22, 2026 | Sell | PHVS | Peng Lu | Chief Medical Officer | 14,202 | $16.32 | $2.4B | -4.54% | +82.74% | $231.8K | +0.00% | 10b5-1 | — |
| Apr 22, 2026 | Sell | PHVS | Anne Lesage | Chief Early Development | 22,300 | $22.40 | $2.4B | -4.54% | +82.74% | $499.6K | -0.87% | 10b5-1 | — |
| Apr 16, 2026 | Sell | PHVS | Peng Lu | Chief Medical Officer | 226 | $28.78 | $2.4B | -4.54% | +82.74% | $6.5K | -0.34% | — | — |
| Apr 16, 2026 | Sell | PHVS | Berndt Modig | Chief Executive Officer | 2,292 | $28.60 | $2.4B | -4.54% | +82.74% | $65.6K | -1.61% | — | — |
| Apr 11, 2026 | Sell | PHVS | Anna Nijdam | Principal Accounting Officer | 548 | $26.63 | $2.4B | -4.54% | +82.74% | $14.6K | -1.11% | — | — |
| Apr 9, 2026 | Sell | PHVS | Berndt Modig | Chief Executive Officer | 23,333 | $27.74 | $2.4B | -4.54% | +82.74% | $647.3K | -7.58% | — | — |
| Apr 6, 2026 | Sell | PHVS | Anna Nijdam | Principal Accounting Officer | 1,167 | $28.56 | $2.4B | -4.54% | +82.74% | $33.3K | -2.30% | — | — |
| Apr 1, 2026 | Sell | PHVS | Anna Nijdam | Principal Accounting Officer | 1,164 | $28.25 | $2.4B | -4.54% | +82.74% | $32.9K | -2.25% | — | — |